Detection of the expression levels of VEGFA and VEGFR2 in blood samples of patients with metastatic colorectal cancer are a direct and accurate method to monitor the effects of anti-angiogenesis therapy [31]. The gene discussed is VEGFA; the disease is metastatic colorectal cancer.